MIA WEISS, MD

Injection, pegfilgrastim, excludes biosimilar, 0.5 mg

Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l

Biopsy and aspiration of bone marrow sample for diagnosis

Administration of chemotherapy into vein, 1 hour or less

Administration of chemotherapy into vein using push technique

New patient office or other outpatient visit, 45-59 minutes

Administration of additional new drug or substance into vein, 1 hour or less

Administration of additional new drug or substance into vein using push technique

Injection, irinotecan, 20 mg

Established patient office or other outpatient visit, 30-39 minutes

Transfusion of blood or blood products

Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

Infusion into a vein for hydration, 31-60 minutes

Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less

Administration of chemotherapy into vein, each additional hour

Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg

Cyclophosphamide, 100 mg

Collection of blood sample from implanted device

Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg

Established patient office or other outpatient visit, 20-29 minutes

Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle

Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg

Injection of additional new drug or substance into vein

Infusion into a vein for therapy, prevention, or diagnosis, each additional hour

Infusion into a vein for hydration, each additional hour

Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion

Injection, pembrolizumab, 1 mg

Injection, zoledronic acid, 1 mg

Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg

Injection of drug or substance under skin or into muscle

Injection, palonosetron hcl, 25 mcg

Injection, denosumab, 1 mg

Insertion of needle into vein for collection of blood sample

Infusion, normal saline solution , 1000 cc

Injection, diphenhydramine hcl, up to 50 mg

Injection, fluorouracil, 500 mg

Injection, carboplatin, 50 mg

Injection, leucovorin calcium, per 50 mg

Unclassified drugs

Injection, etoposide, 10 mg

Injection, doxorubicin hydrochloride, 10 mg

Injection, azacitidine, 1 mg

Injection, granisetron hydrochloride, 100 mcg

Injection, oxaliplatin, 0.5 mg

Injection, fosaprepitant, 1 mg

Injection, dexamethasone sodium phosphate, 1 mg

Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram

Injection, atropine sulfate, 0.01 mg

Injection, paclitaxel, 1 mg